Articles | EuroIntervention

10.4244/EIJV9I1A15 • May 21, 2013

Contemporary retrograde approach for the recanalisation of coronary chronic total occlusion: on behalf of the Japanese Retrograde Summit Group

Yamane M, Muto M, Matsubara T, Nakamura S, Muramatsu T, Oida A, Igarashi Y, Nozaki Y, Kijima M, Tuschikane E

free

10.4244/EIJV9I1A16 • May 21, 2013

Impact of ad hoc percutaneous coronary intervention with drug-eluting stents in angina patients

Kim Y, Park D, Ahn J, Park G-M, Cho Y-R, Lee J, Kim W-J, Yun S-C, Kang S, Lee S, Lee C, Park S, Park S

free

10.4244/EIJV9I1A17 • May 21, 2013

Bivalirudin in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: outcomes in a large real-world population

Shelton R, Eftychiou C, Somers K, Liu A, Burton-Wood N, Anderson M, Makri L, Blaxill J, McLenachan J, Wheatcroft S, Greenwood J, Blackman D

free

10.4244/EIJV9I1A18 • May 21, 2013

Clinical and angiographic outcomes following first-in-man implantation of a novel thin-strut low-profile fixed-wire stent: the Svelte Coronary Stent Integrated Delivery System first-in-man trial

Diletti R, Garcia-Garcia H, Bourantas C, van Geuns R, Van Mieghem NM, Agostoni P, Muramatsu T, Farooq V, Spencer R, de Schepper J, Pomeranz M, Stella P, Serruys PW

free

10.4244/EIJV9I1A19 • May 21, 2013

A novel non-vascular system to treat resistant hypertension

Heuser R, Mhatre A, Buelna T, Berci W, Hubbard B

free

10.4244/EIJV9I1A20 • May 21, 2013

Ethanol-mediated perivascular renal sympathetic denervation: preclinical validation of safety and efficacy in a porcine model

Fischell T, Vega F, Raju N, Johnson E, Kent D, Ragland R, Fischell D, Almany S, Ghazarossian V

free

10.4244/EIJV9I1A21 • May 21, 2013

Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter

Lemos P, Farooq V, Takimura C, Gutierrez P, Virmani R, Kolodgie F, Christians U, Kharlamov A, Doshi M, Sojitra P, van Beusekom H, Serruys PW

free

10.4244/EIJV9I1A22 • May 21, 2013

How should I treat a patient with typical angina, typical angiography, negative FFR?

Jabs A, Hink U, Fineschi M, Munzel T, Gori T

free

10.4244/EIJV9I1A23 • May 21, 2013

Tools & Techniques: Analysis of clustered data in interventional cardiology: current practice and methodological advice

Lingsma H, Nauta S, van Leeuwen N, Borsboom G, Bruining N, Steyerberg E

free

10.4244/EIJV9I1A24 • May 21, 2013

“First-in-man” use of bioresorbable vascular scaffold in saphenous vein graft

Ong P, Jafary F, Ho HH

free

10.4244/EIJV9I1A25 • May 21, 2013

Lesion distribution and intrinsic variability: the challenge to beat the gold standard

van de Hoef TP, Meuwissen M, Piek J

free

10.4244/EIJV9I1A26 • May 21, 2013

Commentary on “Hybrid iFR-FFR decision-making strategy…” by Petraco et al

El-Omar M, Mamas MA

free

• May 21, 2013

EAPCI Focus on the Italian Society of Interventional Cardiology (SICI-GISE)

free

10.4244/EIJV9SRA1 • May 21, 2013

Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects

Kjeldsen S, Os I, Mahfoud F

free

10.4244/EIJV9SRA2 • May 21, 2013

Charting new frontiers in interventional medicine

Fajadet J

free